Skip to main content

Want a detailed portfolio tracker?

Amarin (AMRN) Total Debt (2008 - 2026)

Amarin (AMRN) total debt from Dec 31, 2008 to Mar 31, 2026. The current Amarin (AMRN) total debt is $196M. You can adjust inflation or export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Total Debt

Total Debt

Amarin (AMRN) Total Debt CAGR table

PeriodCAGR
1 Year TTM-4.06%
3 Years TTM-14.00%
5 Years TTM-9.75%
10 Years TTM-3.72%

Annual Total Debt change of Amarin (AMRN)

YearTotal DebtChange
2025$211M
+6.19%
2024$199M
-28.76%
2023$280M
-3.87%
2022$291M
-27.46%
2021$401M
+18.45%
2020$339M
+23.57%
2019$274M
+17.38%
2018$233M
+2.95%
2017$227M
+28.76%
2016$176M
-41.47%
2015$301M
+15.88%
2014$260M
-9.35%
2013$286M
-9.06%
2012$315M
+137.91%
2011$132M
-44.33%
2010$238M
N/A
2009$0
N/A
2008$0
N/A

Comparison Amarin (AMRN) total debt with competitors

Amarin (AMRN) total debt is $196.35M.

TickerNameTotal DebtUpside
MIRAMira Pharmaceuticals Inc$114761.00-99.94%
NSRXNasus Pharma Ltd$2.24M-98.86%
MDCXMDCorp$6.00M-96.94%
MDCXWMedicus Pharma Ltd warrant$6.00M-96.94%
SCLXScilex Holding Company$547.71M+178.94%
BIIBBiogen Inc$10.83B+5416.37%
OGNOrganon & Company$12.09B+6058.90%
GRFSGrifols SA$12.24B+6135.68%
SNYSanofi$54.88B+27850.60%
GSKGSK Plc$59.93B+30422.52%
BMYBristol-Myers Squibb Company$66.37B+33703.92%
AZNAstrazeneca plc$66.63B+33834.81%
NVSNovartis AG$79.61B+40442.40%
PFEPfizer Inc$117.21B+59596.46%
JNJJohnson & Johnson$119.71B+60866.64%
NVONovo Nordisk$356.16B+181288.34%